Literature DB >> 9384607

Biosynthesis and intracellular targeting of the CLN3 protein defective in Batten disease.

I Järvelä1, M Sainio, T Rantamäki, V M Olkkonen, O Carpén, L Peltonen, A Jalanko.   

Abstract

Batten disease (juvenile-onset neuronal ceroid lipofuscinosis, JNCL), the most common neurodegenerative disorder of childhood, is caused by mutations in a recently identified gene ( CLN3 ) localized to chromosome 16p11.2-12.1. To elucidate the biosynthesis and localization of the CLN3 protein, we expressed CLN3 cDNA in COS-1 and HeLa cell lines. In vitro translation, immunoprecipitation and Western blotting analyses detected an approximately 43 kDa polypeptide. Pulse-chase experiments indicated that the CLN3 protein is synthesized as an N -glycosylated single-chain polypeptide, which was not detected in growth medium. Confocal immunofluorescence microscopy revealed that the CLN3 protein is localized to the lysosomal compartment. These results provide evidence that Batten disease can be classified as a member of lysosomal diseases.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9384607     DOI: 10.1093/hmg/7.1.85

Source DB:  PubMed          Journal:  Hum Mol Genet        ISSN: 0964-6906            Impact factor:   6.150


  42 in total

Review 1.  The Finnish Disease Heritage III: the individual diseases.

Authors:  Reijo Norio
Journal:  Hum Genet       Date:  2003-03-08       Impact factor: 4.132

2.  Two motifs target Batten disease protein CLN3 to lysosomes in transfected nonneuronal and neuronal cells.

Authors:  Aija Kyttälä; Gudrun Ihrke; Jouni Vesa; Michael J Schell; J Paul Luzio
Journal:  Mol Biol Cell       Date:  2003-12-29       Impact factor: 4.138

3.  Neuronal ceroid lipofuscinosis protein CLN3 interacts with motor proteins and modifies location of late endosomal compartments.

Authors:  Kristiina Uusi-Rauva; Aija Kyttälä; Rik van der Kant; Jouni Vesa; Kimmo Tanhuanpää; Jacques Neefjes; Vesa M Olkkonen; Anu Jalanko
Journal:  Cell Mol Life Sci       Date:  2012-01-20       Impact factor: 9.261

Review 4.  Correlations between genotype, ultrastructural morphology and clinical phenotype in the neuronal ceroid lipofuscinoses.

Authors:  Sara E Mole; Ruth E Williams; Hans H Goebel
Journal:  Neurogenetics       Date:  2005-09-28       Impact factor: 2.660

5.  Deletion of the Caenorhabditis elegans homologues of the CLN3 gene, involved in human juvenile neuronal ceroid lipofuscinosis, causes a mild progeric phenotype.

Authors:  G de Voer; P van der Bent; A J G Rodrigues; G-J B van Ommen; D J M Peters; P E M Taschner
Journal:  J Inherit Metab Dis       Date:  2005       Impact factor: 4.982

6.  Specific alterations in levels of mannose 6-phosphorylated glycoproteins in different neuronal ceroid lipofuscinoses.

Authors:  D E Sleat; I Sohar; P S Pullarkat; P Lobel; R K Pullarkat
Journal:  Biochem J       Date:  1998-09-15       Impact factor: 3.857

7.  S. pombe btn1, the orthologue of the Batten disease gene CLN3, is required for vacuole protein sorting of Cpy1p and Golgi exit of Vps10p.

Authors:  Sandra Codlin; Sara E Mole
Journal:  J Cell Sci       Date:  2009-03-19       Impact factor: 5.285

8.  Interaction between Sdo1p and Btn1p in the Saccharomyces cerevisiae model for Batten disease.

Authors:  Seasson Phillips Vitiello; Jared W Benedict; Sergio Padilla-Lopez; David A Pearce
Journal:  Hum Mol Genet       Date:  2009-12-16       Impact factor: 6.150

9.  A role in vacuolar arginine transport for yeast Btn1p and for human CLN3, the protein defective in Batten disease.

Authors:  Yoojin Kim; Denia Ramirez-Montealegre; David A Pearce
Journal:  Proc Natl Acad Sci U S A       Date:  2003-12-05       Impact factor: 11.205

10.  Novel interactions of CLN5 support molecular networking between Neuronal Ceroid Lipofuscinosis proteins.

Authors:  Annina Lyly; Carina von Schantz; Claudia Heine; Mia-Lisa Schmiedt; Tessa Sipilä; Anu Jalanko; Aija Kyttälä
Journal:  BMC Cell Biol       Date:  2009-11-26
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.